Contents
Download PDF
pdf Download XML
269 Views
98 Downloads
Share this article
Research Article | Volume 13 Issue:3 (, 2023) | Pages 435 - 438
Diagnostic Utility of Immunohistochemical Markers Ck7, Ck 20 and CEA in Surface epithelial Tumors of Ovary
Under a Creative Commons license
Open Access
Received
July 5, 2023
Revised
July 19, 2023
Accepted
July 28, 2023
Published
Aug. 1, 2023
Abstract

Background: Immunohistochemistry is the definitive diagnosis in cases where a definite diagnosis cannot be made morphologically and histologically. IHC helps classify tumors. It also helps to solve the diagnosis problem of benign and malignant tumors. Material And Methods:  We studied 100 different ovarian epithelial tumors over a 2 year period. Three immune markers were included in the study. Result: Out of 100 case 70% are benign and 30%  aremalignant.Serous cystadenoma was most common benign lesion(60%)& among malignant lesions Serous cystadenocarcinoma was most common(60%).83.33% cases of serous carcinoma showed positivity for CK7 & 100% negativity for CK20 & CEA Conclusion: IHC helps to classify and confirm the histological diagnosis. IHC is particularly useful in solving the diagnostic problem of ovarian cancer and is poorly differentiated.

Keywords
Recommended Articles
Research Article
Study the effects of obesity on blood glucose levels in adolescents in Central Uttar Pradesh - An observational cross - sectional study
...
Published: 11/09/2025
Download PDF
Research Article
Evaluation of Ultrasonographic Strain Elastography in Differentiating Benign and Malignant Thyroid Nodules: A Histopathology-Correlated Study
Published: 11/09/2025
Download PDF
Research Article
Sugammadex Versus Neostigmine for Reversal of Rocuronium Block: Recovery Profile and Adverse Events- A Comparative Study
Published: 11/09/2025
Download PDF
Research Article
Prevalence and Associated Factors of Dysmenorrhea among College-Going Girls in Jhalawar District, Rajasthan
...
Published: 11/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.